Randomized controlled study of probiotics containing Lactobacillus casei (Shirota strain) for prevention of ventilator-associated pneumonia

Journal of the Medical Association of Thailand

Volumn 98, Issue 3, 2015, Pages 253-259

  Rongrungruang, Yong ^a   Krajangwittaya, Donnaya ^a   Pholtawornkulchai, Kittisak ^b   Tiengrim, Surapee ^a   Thamlikitkul, Visanu ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

Author keywords

Lactobacillus casei (Shirota strain); Prevention; Probiotics; Ventilator associated pneumonia

Indexed keywords

CHLORHEXIDINE; PROBIOTIC AGENT;

ACINETOBACTER BAUMANNII; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DAIRY PRODUCT; DIARRHEA; ENTERIC FEEDING; ESCHERICHIA COLI; FEMALE; HOSPITALIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; LACTOBACILLUS CASEI; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MOUTH HYGIENE; OPEN STUDY; OROPHARYNX; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; RECTUM; VENTILATOR ASSOCIATED PNEUMONIA; VERY ELDERLY; ADVERSE EFFECTS; BACTERIUM; INCIDENCE; ISOLATION AND PURIFICATION; LENGTH OF STAY; MECHANICAL VENTILATOR; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PREVALENCE;

ADULT; AGED; BACTERIA; FEMALE; HUMANS; INCIDENCE; LACTOBACILLUS CASEI; LENGTH OF STAY; MALE; MIDDLE AGED; OROPHARYNX; PNEUMONIA, VENTILATOR-ASSOCIATED; PREVALENCE; PROBIOTICS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; VENTILATORS, MECHANICAL;

EID: 84929513868     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Danchaivijitr S, Dhiraputra C, Santiprasitkul S, Judaeng T. Prevalence and impacts of nosocomial infection in Thailand 2001. J Med Assoc Thai 2005; 88 (Suppl 10): S1-9.
2. Hayakawa M, Asahara T, Ishitani T, Okamura A, Nomoto K, Gando S. Synbiotic therapy reduces the pathological gram-negative rods caused by an increased acetic acid concentration in the gut. Dig Dis Sci 2012; 57: 2642-9.
3. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilatorassociated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
4. Kollef MH. Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med 2004; 32: 1396-405.
5. Cook D. Ventilator associated pneumonia: perspectives on the burden of illness. Intensive Care Med 2000; 26 (Suppl 1): S31-7.
6. Babcock HM, Zack JE, Garrison T, Trovillion E, Jones M, Fraser VJ, et al. An educational intervention to reduce ventilator-associated pneumonia in an integrated health system: a comparison of effects. Chest 2004; 125: 2224-31.
7. Kollef MH, Afessa B, Anzueto A, Veremakis C, Kerr KM, Margolis BD, et al. Silver-coated endotracheal tubes and incidence of ventilatorassociated pneumonia: the NASCENT randomized trial. JAMA 2008; 300: 805-13.
8. Gill H, Prasad J. Probiotics, immunomodulation, and health benefits. Adv Exp Med Biol 2008; 606: 423-54.
9. Rello J, Lode H, Cornaglia G, Masterton R. A European care bundle for prevention of ventilatorassociated pneumonia. Intensive Care Med 2010; 36: 773-80.
10. Vimala Y, Dileep P. Some aspects of probiotics. Indian J Microbiol 2006; 46: 1-7.
11. Goldin BR, Gorbach SL. Clinical indications for probiotics: an overview. Clin Infect Dis 2008; 46 (Suppl 2): S96-100.
12. Siempos II, Ntaidou TK, Falagas ME. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med 2010; 38: 954-62.
13. Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med 2010; 182: 1058-64.
14. Barraud D, Blard C, Hein F, Marcon O, Cravoisy A, Nace L, et al. Probiotics in the critically ill patient: a double blind, randomized, placebocontrolled trial. Intensive Care Med 2010; 36: 1540-7.
15. Knight DJ, Gardiner D, Banks A, Snape SE, Weston VC, Bengmark S, et al. Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Intensive Care Med 2009; 35: 854-61.
16. Forestier C, Guelon D, Cluytens V, Gillart T, Sirot J, De Champs C. Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Crit Care 2008; 12: R69.
17. Klarin B, Molin G, Jeppsson B, Larsson A. Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study. Crit Care 2008; 12: R136.
18. Spindler-Vesel A, Bengmark S, Vovk I, Cerovic O, Kompan L. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. J Parenter Enteral Nutr 2007; 31: 119-26.
19. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E. Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial. World J Surg 2006; 30: 1848-55.
20. Wang J, Liu KX, Ariani F, Tao LL, Zhang J, Qu JM. Probiotics for preventing ventilator-associated pneumonia: a systematic review and meta-analysis of high-quality randomized controlled trials. PLoS One 2013; 8: e83934.
21. Tiengrim S, Thamlikitkul V. Inhibitory activity of fermented milk with Lactobacillus casei strain Shirota against common multidrug-resistant bacteria causing hospital-acquired infections. J Med Assoc Thai 2012; 95 (Suppl 2): S1-5.
22. Tiengrim S, Leelaporn A, Manatsathit S, Thamlikitkul V. Viability of Lactobacillus casei strain Shirota (LcS) from feces of Thai healthy subjects regularly taking milk product containing LcS. J Med Assoc Thai 2012; 95 (Suppl 2): S42-7.
23. Gleeson M, Bishop NC, Oliveira M, Tauler P. Daily probiotic’s (Lactobacillus casei Shirota) reduction of infection incidence in athletes. Int J Sport Nutr Exerc Metab 2011; 21: 55-64.
24. Srinivasan R, Meyer R, Padmanabhan R, Britto J. Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children. J Pediatr Gastroenterol Nutr 2006; 42: 171-3.